Variant report
Variant | esv3426086 |
---|---|
Chromosome Location | chr16:82258403-82263911 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:19)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:19 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:81973203..81974111-chr16:82263361..82264340,4 | K562 | blood: | |
2 | chr16:82263588..82264475-chr17:60186661..60187255,2 | MCF-7 | breast: | |
3 | chr16:82135638..82136440-chr16:82263371..82264096,2 | MCF-7 | breast: | |
4 | chr16:82095196..82096036-chr16:82263712..82264246,2 | MCF-7 | breast: | |
5 | chr16:81974180..81974994-chr16:82263377..82264081,3 | MCF-7 | breast: | |
6 | chr16:82049544..82050394-chr16:82263299..82263885,2 | MCF-7 | breast: | |
7 | chr16:82064722..82065718-chr16:82262987..82264266,17 | MCF-7 | breast: | |
8 | chr16:82064816..82065363-chr16:82261080..82262041,2 | MCF-7 | breast: | |
9 | chr16:82253625..82256227-chr16:82257466..82259269,2 | MCF-7 | breast: | |
10 | chr16:81923911..81924649-chr16:82263311..82264070,2 | K562 | blood: | |
11 | chr16:81974143..81975083-chr16:82263601..82264236,3 | K562 | blood: | |
12 | chr16:82064738..82065659-chr16:82263372..82264240,11 | MCF-7 | breast: | |
13 | chr16:82202815..82205147-chr16:82258827..82261790,2 | MCF-7 | breast: | |
14 | chr16:82255757..82258661-chr16:82260604..82263594,2 | K562 | blood: | |
15 | chr16:82263616..82264267-chr16:82377230..82378064,2 | MCF-7 | breast: | |
16 | chr16:82211064..82211822-chr16:82263223..82264188,4 | MCF-7 | breast: | |
17 | chr16:82065223..82067133-chr16:82262887..82264649,2 | MCF-7 | breast: | |
18 | chr16:82064756..82065405-chr16:82263533..82264299,2 | K562 | blood: | |
19 | chr16:82255757..82258661-chr16:82260604..82263594,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261029 | chromatin interactions |
ENSG00000135698 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574467242 | chr16:82258405-82258406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200099780 | chr16:82258411-82258412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201066139 | chr16:82258413-82258414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71689487 | chr16:82258414-82258415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542902005 | chr16:82258415-82258416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71146070 | chr16:82258416-82258417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199709156 | chr16:82258417-82258418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200575516 | chr16:82258418-82258419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555183584 | chr16:82258497-82258498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576674155 | chr16:82258505-82258506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7185760 | chr16:82258581-82258582 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs557534830 | chr16:82258621-82258622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148227611 | chr16:82258626-82258627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35540161 | chr16:82258634-82258635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140090266 | chr16:82258640-82258641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559637266 | chr16:82258651-82258652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75629078 | chr16:82258669-82258670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548118732 | chr16:82258671-82258672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185448917 | chr16:82258675-82258676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62046763 | chr16:82258705-82258706 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs137914199 | chr16:82258730-82258731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527411483 | chr16:82258748-82258749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs58169377 | chr16:82258799-82258800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552932761 | chr16:82258834-82258835 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs553720420 | chr16:82258868-82258869 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs117766278 | chr16:82258874-82258875 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs144051335 | chr16:82258875-82258876 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs576711137 | chr16:82258902-82258903 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs537601059 | chr16:82258933-82258934 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs189307996 | chr16:82258951-82258952 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs181966329 | chr16:82258986-82258987 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs541095121 | chr16:82259002-82259003 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs77155306 | chr16:82259017-82259018 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs574707954 | chr16:82259026-82259027 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs58370774 | chr16:82259051-82259052 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs113390941 | chr16:82259137-82259138 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs147331990 | chr16:82259194-82259195 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs2932840 | chr16:82259199-82259200 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs183580612 | chr16:82259206-82259207 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs564273685 | chr16:82259249-82259250 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs114119239 | chr16:82259301-82259302 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs116479991 | chr16:82259309-82259310 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs572122282 | chr16:82259325-82259326 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs188220414 | chr16:82259334-82259335 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs113780772 | chr16:82259337-82259338 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs376221929 | chr16:82259341-82259342 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs139210395 | chr16:82259378-82259379 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs561977424 | chr16:82259387-82259388 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs568963152 | chr16:82259392-82259393 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs570026453 | chr16:82259430-82259431 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16461572 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:82254600-82260000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr16:82259200-82259800 | Enhancers | Colon Smooth Muscle | Colon |
3 | chr16:82260000-82260600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr16:82262000-82262200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr16:82262200-82263400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr16:82263000-82263400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr16:82263200-82263400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr16:82263200-82263400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr16:82263200-82264200 | Enhancers | Stomach Mucosa | stomach |
10 | chr16:82263400-82263800 | Enhancers | Duodenum Mucosa | Duodenum |
11 | chr16:82263400-82263800 | Enhancers | Fetal Intestine Small | intestine |
12 | chr16:82263400-82263800 | Enhancers | Placenta | Placenta |
13 | chr16:82263400-82264200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr16:82263600-82263800 | Enhancers | Fetal Kidney | kidney |
15 | chr16:82263800-82264800 | Weak transcription | Duodenum Mucosa | Duodenum |
16 | chr16:82263800-82265200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
17 | chr16:82263800-82265600 | Enhancers | Rectal Mucosa Donor 29 | rectum |